CoChat
Sign Up
Cited by 94

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Age-Associated Loss of Bone Marrow Hematopoietic Cells Is Reversed by GH and Accompanies Thymic Reconstitution

French, Richard A., Broussard, Suzanne R., Meier, William A., Minshall, Christian, Arkins, Sean, Zachary, James F., Dantzer, Robert, Kelley, Keith W.·2002·Endocrinology
DOI 10.1210/endo.143.2.8612
Open this paper in CoChat — free account

Abstract

Deterioration of the thymus gland during aging is accompanied by a reduction in plasma GH. Here we report gross and microscopic results from 24-month-old Wistar-Furth rats treated with rat GH derived from syngeneic GH3 cells or with recombinant human GH. Histological evaluation of aged rats treated with either rat or human GH displayed clear morphologic evidence of thymic regeneration, reconstitution of hematopoietic cells in the bone marrow, and multiorgan extramedullary hematopoiesis. Quantitative evaluation of formalin-fixed, hematoxylin and eosin-stained sections of bone marrow from aged rats revealed at least a 50% reduction in the number hematopoietic bone marrow cells, compared with that of young 3-month-old rats. This age-associated decline in bone marrow leukocytes, as well as the increase in bone marrow adipocytes, was significantly reversed by in vivo treatment with GH. Restoration of bone marrow cellularity was caused primarily by erythrocytic and granulocytic cells, but all cell lineages were represented and their proportions were similar to those in aged control rats. On a per-cell basis, GH treatment in vivo significantly increased the number of in vitro myeloid colony forming units in both bone marrow and spleen. Morphological evidence of enhanced extramedullary hematopoiesis was observed in the spleen, liver, and adrenal glands from animals treated with GH. These results confirm that GH prevents thymic aging. Furthermore, these data significantly extend earli…

Overview

Integrity signals

Registry

Crossref · 10.1210/endo.143.2.8612

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 68

  1. Lamberts, 1997, The endocrinology of aging., Science, 278, 419, 10.1126/science.278.5337.419 · DOI · Paper page
  2. Mackall, 1995, Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy., N Engl J Med, 332, 143, 10.1056/NEJM199501193320303 · DOI · Paper page
  3. Goya, 1992, In vivo effects of growth hormone on thymus function in aging mice., Brain Behav Immun, 6, 341, 10.1016/0889-1591(92)90033-K · DOI
  4. Kelley, 1986, GH3 pituitary adenoma cells can reverse thymic aging in rats., Proc Natl Acad Sci USA, 83, 5663, 10.1073/pnas.83.15.5663 · DOI · Paper page
  5. Knyszynski, 1992, Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow., Brain Behav Immun, 6, 327, 10.1016/0889-1591(92)90032-J · DOI
  6. Goff, 1987, Growth hormone treatment stimulates thymulin production in aged dogs., Clin Exp Immunol, 68, 580
  7. Murphy, 1992, Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice., Proc Natl Acad Sci USA, 89, 4481, 10.1073/pnas.89.10.4481 · DOI
  8. Murphy, 1992, Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma., Brain Behav Immun, 6, 355, 10.1016/0889-1591(92)90034-L · DOI
  9. Murphy, 1992, Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo., J Immunol, 149, 3851, 10.4049/jimmunol.149.12.3851 · DOI
  10. Murphy, 1992, Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice., J Immunol, 148, 3799, 10.4049/jimmunol.148.12.3799 · DOI
  11. Murphy, 1993, Differential effects of growth hormone and prolactin on murine T cell development and function., J Exp Med, 178, 231, 10.1084/jem.178.1.231 · DOI
  12. Berczi, 1991, Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue., J Immunol, 146, 2201, 10.4049/jimmunol.146.7.2201 · DOI
  13. Murphy, 1992, Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine., Blood, 80, 1443, 10.1182/blood.V80.6.1443.1443 · DOI
  14. Beschorner, 1991, Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I., Transplantation, 52, 879, 10.1097/00007890-199111000-00024 · DOI
  15. Davila, 1987, Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents., J Neurosci Res, 18, 108, 10.1002/jnr.490180118 · DOI
  16. Li, 1992, Pituitary epithelial cell implants reverse the accumulation of CD4−CD8− lymphocytes in thymus glands of aged rats., Endocrinology, 130, 2703, 10.1210/endo.130.5.1572290 · DOI
  17. Dubiski, 1989, Strain polymorphism in progression of aging: changes in CD4, CD8 bearing subpopulations., Immunol Lett, 23, 1, 10.1016/0165-2478(89)90147-8 · DOI
  18. Gagnerault, 1996, Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry., Endocrinology, 137, 1719, 10.1210/endo.137.5.8612507 · DOI
  19. Dardenne, 1998, Growth hormone receptors and immunocompetent cells., Ann NY Acad Sci, 840, 510, 10.1111/j.1749-6632.1998.tb09589.x · DOI
  20. Kooijman, 1995, Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes., J Endocrinol, 147, 203, 10.1677/joe.0.1470203 · DOI
  21. Ban, 1991, Specific binding sites for growth hormone in cultured mouse thymic epithelial cells., Life Sci, 48, 2141, 10.1016/0024-3205(91)90147-4 · DOI
  22. Timsit, 1992, Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells., J Clin Endocrinol Metab, 75, 183
  23. Eren, 1990, Quantitative analysis of bone marrow thymic progenitors in young and aged mice., Cell Immunol, 127, 238, 10.1016/0008-8749(90)90129-F · DOI
  24. McCormick, 1991, Bone marrow-thymus axis in senescence., Am J Anat, 191, 321, 10.1002/aja.1001910312 · DOI
  25. Montecino-Rodriguez, 1998, Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice., Endocrinology, 139, 4120, 10.1210/endo.139.10.6263 · DOI · Paper page
  26. Nagy, 1989, Pituitary dependence of bone marrow function., Br J Haematol, 71, 457, 10.1111/j.1365-2141.1989.tb06302.x · DOI
  27. Tian, 1998, Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice., Stem Cells, 16, 193, 10.1002/stem.160193 · DOI
  28. Welniak, 2000, Effects of growth hormone and prolactin on hematopoiesis., Leuk Lymphoma, 38, 435, 10.3109/10428190009059263 · DOI
  29. Woody, 1999, Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation., Neuroimmunomodulation, 6, 69, 10.1159/000026366 · DOI
  30. Burgess, 1999, The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I., Neuroimmunomodulation, 6, 56, 10.1159/000026365 · DOI
  31. Davila, 1990, Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis factor-α declines in macrophages from aged rats., FASEB J, 4, 2906, 10.1096/fasebj.4.11.2165948 · DOI
  32. Moloney, 1969, Observations on leukemia in Wistar Furth rats., Cancer Res, 29, 938
  33. Arkins, 1995, The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis., Endocrinology, 136, 1153, 10.1210/endo.136.3.7532579 · DOI
  34. French, 1996, Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone., Endocrinology, 137, 4027, 10.1210/endo.137.9.8756580 · DOI
  35. French, 1999, Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice., J Neuroimmunol, 93, 194, 10.1016/S0165-5728(98)00224-0 · DOI · Paper page
  36. Heyworth, 1993, In vitro clonal assays for murine multi-potential and lineage restricted myeloid progenitor cells, 37
  37. Fernholm, 2000, Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease., J Clin Endocrinol Metab, 85, 4104
  38. Lamberts, 2000, The somatopause: to treat or not to treat?, Horm Res, 53, 42
  39. Dorshkind, 2000, The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency., Endocr Rev, 21, 292
  40. Blazar, 1995, Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo., Exp Hematol, 23, 1397
  41. Ten Have, 1997, Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy., Clin Endocrinol (Oxf), 47, 565, 10.1046/j.1365-2265.1997.3241124.x · DOI
  42. Kooijman, 1996, Prolactin, growth hormone, and insulin-like growth factor-I in the immune system., Adv Immunol, 63, 377, 10.1016/S0065-2776(08)60860-3 · DOI
  43. Vines, 2000, Identification of SP3 as a negative regulatory transcription factor in the monocyte expression of growth hormone., Endocrinology, 141, 938, 10.1210/endo.141.3.7381 · DOI
  44. Recher, 2001, Prenatal and adult growth hormone gene expression in rat lymphoid organs., J Histochem Cytochem, 49, 347, 10.1177/002215540104900309 · DOI
  45. Weigent, 1997, Production of peptide hormones and neurotransmitters by the immune system., Chem Immunol, 69, 1, 10.1159/000058652 · DOI
  46. Kecha, 2000, Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures., Endocrinology, 141, 1209, 10.1210/endo.141.3.7360 · DOI
  47. Etherton, 2000, The biology of somatotropin in adipose tissue growth and nutrient partitioning., J Nutr, 130, 2623, 10.1093/jn/130.11.2623 · DOI
  48. Sachs, 1996, The control of hematopoiesis and leukemia: from basic biology to the clinic., Proc Natl Acad Sci USA, 93, 4742, 10.1073/pnas.93.10.4742 · DOI
  49. Merchav, 1998, The haematopoietic effects of growth hormone and insulin-like growth factor-I., J Pediatr Endocrinol Metab, 11, 677, 10.1515/JPEM.1998.11.6.677 · DOI
  50. Minshall, 1996, Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor., J Immunol, 156, 939, 10.4049/jimmunol.156.3.939 · DOI
  51. Liu, 1999, Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27KIP1 inhibitor characterize early development of promyeloid cells into macrophages., Mol Cell Biol, 19, 6229, 10.1128/MCB.19.9.6229 · DOI
  52. Liu, 1997, Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes., J Immunol, 159, 829, 10.4049/jimmunol.159.2.829 · DOI
  53. Minshall, 1999, Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors., J Immunol, 162, 4542, 10.4049/jimmunol.162.8.4542 · DOI
  54. Liu, 1998, Activation of protein kinase C-ζ and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I., J Immunol, 160, 1393, 10.4049/jimmunol.160.3.1393 · DOI
  55. Aspinall, 2000, Thymic involution in aging., J Clin Immunol, 20, 250, 10.1023/A:1006611518223 · DOI
  56. Haynes, 2001, The human thymus during aging., Immunol Res, 22, 253, 10.1385/IR:22:2-3:253 · DOI
  57. Haynes, 2000, The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection., Annu Rev Immunol, 18, 529, 10.1146/annurev.immunol.18.1.529 · DOI
  58. Andrew, 2001, IL-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice., J Immunol, 166, 1524, 10.4049/jimmunol.166.3.1524 · DOI
  59. George, 1996, Thymic involution with ageing: obsolescence or good housekeeping?, Immunol Today, 17, 267, 10.1016/0167-5699(96)80543-3 · DOI
  60. Koo, 2001, Immune enhancing effect of a growth hormone secretagogue., J Immunol, 166, 4195, 10.4049/jimmunol.166.6.4195 · DOI
  61. Fu, 1991, A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion., J Immunol, 146, 1602, 10.4049/jimmunol.146.5.1602 · DOI
  62. Fu, 1992, Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor., J Clin Invest, 89, 451, 10.1172/JCI115605 · DOI
  63. Edwards, 1988, A newly defined property of somatotropin: priming of macrophages for production of superoxide anion., Science, 239, 769, 10.1126/science.2829357 · DOI
  64. Edwards, 1991, The pituitary gland is required for protection against lethal effects of Salmonella typhimurium., Proc Natl Acad Sci USA, 88, 2274, 10.1073/pnas.88.6.2274 · DOI · Paper page
  65. Fu, 1994, Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone., Infect Immun, 62, 1, 10.1128/IAI.62.1.1-8.1994 · DOI
  66. Gelato, 2000, The growth hormone/insulin-like growth factor axis in critical illness, J Pediatr Endocrinol Metab, 13, 1023
  67. Khansari, 1991, Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice., Mech Ageing Dev, 57, 87, 10.1016/0047-6374(91)90026-V · DOI
  68. Murphy, 2000, Growth hormone as an immunomodulating therapeutic agent., Immunol Today, 21, 211, 10.1016/S0167-5699(00)01594-2 · DOI

Cited by

Sorted by citations

See all 94

Metadata

Authors
French, R. A., Broussard, S. R., Meier, W. A., Minshall, C., Arkins, S., Zachary, J. F., Dantzer, R., & Kelley, K. W.
Affiliations
  • Laboratory of Immunophysiology (R.A.F., S.R.B., C.M., S.A., K.W.K.), University of Illinois at Urbana-Champaign, Urbana, Illinois 61801
  • Department of Animal Sciences, and Department of Veterinary Pathobiology (W.A.M., J.F.Z.), University of Illinois at Urbana-Champaign, Urbana, Illinois 61801
  • Institut National de la Recherche Agronomique-Institut National de la Santé et de la Recherche Médicale Unité 394, Unité de Recherches de Neurobiologie Intégrative (R.D.), Institute François Magendie, 33077 Bordeaux, France
Venue
Endocrinology
Publisher
The Endocrine Society
Published
2002-02-01
Volume
143
Issue
2
Pages
690-699
ISSN
  • 0013-7227
  • 1945-7170
DOI
10.1210/endo.143.2.8612
Cited by
94
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review